학술논문
The decreased serum activity of cytosolic 5′-nucleotidase IA as a potential marker of breast cancer-associated muscle inflammation.
Document Type
Article
Author
Source
Subject
*MYOSITIS
*ADENOSINE monophosphate
*MUSCLE diseases
*PARANEOPLASTIC syndromes
*POLYMYOSITIS
*AUTOANTIBODIES
*SKELETAL muscle
*
*
*
*
*
*
Language
ISSN
1525-7770
Abstract
Cytosolic 5′-nucleotidase IA (cN-IA) plays a central role in the regulation of the purine nucleotide pool in skeletal muscle, preferentially converting adenosine monophosphate to adenosine. cN-IA can act as an autoantigen in muscle diseases, including the paraneoplastic syndrome related to breast cancer (BC). As a result of myocyte damage, released cN-IA protein may trigger the production of anti-cN-IA antibodies (anti-NT5C1A). This work aimed to develop an effective method to measure cN-IA activity in the serum and analyze it in BC patients. Our study demonstrated that serum cN-IA activity was decreased in BC patients and we assumed it is due to the presence of specific autoantibodies. We found correlations between cN-IA activity and parameters of inflammatory muscle damage. Thus, cN-IA is worth further attention to clarify its usefulness as a biomarker of BC-associated polymyositis. [ABSTRACT FROM AUTHOR]